GlassScriptPhysician profile
Ionut B Anton
NPI 1770550238
$9,913.19
in general payments reported to CMS, 2019-2025
42 companies · $1,677 in 2025
The $1,677 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $198 · 2021: $1,588 · 2022: $1,802 · 2023: $1,596 · 2024: $1,803 · 2025: $1,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,788 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,788.24 |
| Education | $288.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,539.95 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $962.28 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $893.54 | 2019-2025 | Jardiance, Ofev |
| Abbvie INC. | $712.30 | 2019-2025 | Ubrelvy, Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $707.95 | 2021-2025 | |
| Lilly USA, LLC | $466.60 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amarin Pharma, INC. | $346.02 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $275.14 | 2019-2025 | Xifaxan |
| Medtronic, INC. | $266.58 | 2021-2025 | Minimed 780g |
| Novartis Pharmaceuticals Corporation | $222.41 | 2019-2025 | |
| Pfizer INC. | $198.45 | 2019-2025 | |
| Exact Sciences Corporation | $173.68 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $160.32 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $159.18 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $152.07 | 2021-2023 | Gattex |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ionut Anton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.